common side effects of trulicity
diarrhea
frequent bowel movements
nausea
retching
other side effects
abdominal distress
abdominal pain
abdominal tenderness
asthenia
dyspepsia
fatigue
gastrointestinal pain
lower abdominal pain
upper abdominal pain
appetite
malaise
comprehensive list of adverse effects
needed effects
dulaglutide
active ingredient
trulicity
unwanted side effects
medical attention
following side effects
taking dulaglutide
check
doctor
dulaglutide side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
common adverse reactions
nausea
diarrhea
vomiting
abdominal pain
appetite
nausea
diarrhea
vomiting
abdominal pain
dyspepsia
constipation
flatulence
abdominal distention
gastroesophageal reflux disease
eructation
lipase
pancreatic amylase increases from baseline
frequency
pancreatitis
clinical trials
greater number of pancreatitis
related adverse reactions
patients
drug
non-incretin comparators
cases
cases
analyses of adjudicated events
cases
confirmed pancreatitis in dulaglutide-exposed patients
case in the non-incretin comparator group
gastrointestinal events
higher dose
cases
patients
mg dose
mg dose
severity of events
clinical trial investigators
case of medullary thyroid carcinoma
mtc
patient
drug
receiving treatment
patient
calcitonin levels
times
upper limit of normal
medullary thyroid carcinoma
hypoglycemia
prandial insulin
decreased appetite
hypoglycemia
drug
combination with a sulfonylurea
insulin
combination with prandial insulin
hypoglycemia
patients
receiving mg
mg
severe hypoglycemia
patients
combination with a sulfonylurea
symptomatic hypoglycemia
add-on therapy
metformin
metformin
pioglitazone
symptomatic hypoglycemia
patients
reports of severe hypoglycemia
clinical trials
mean increase in heart rate
beats per minute
sinus tachycardia
patients
receiving mg
mg of dulaglutide
active ingredient
trulicity
placebo
persistent sinus tachycardia
occurring at more than visits
patients
receiving dulaglutide mg
mg
placebo
episodes of sinus tachycardia
increase
more beats per minute from baseline
patients
first degree av block
sinus tachycardia
pr prolongation on ecgfrequency
increased heart rate
systemic hypersensitivity
severe urticaria
systemic rash
facial edema
lip
clinical studies
n =-rrb- of patients
anti-drug antibodies
adas
half of the patients
dulaglutide-neutralizing antibodies
half
antibodies against native glp
anti-drug antibodies
injection site reactions
fatigue
side effects of trulicity
fda
healthcare professional for medical advice
agitation
change in urination
chills
cold sweats
confusion
cool, pale skin
depression
difficulty with breathing
swallowing
dizziness
fast heartbeat
fever
hives
hoarseness
hostility
increased hunger
irritability
lethargy
loss of appetite
lump in the neck
muscle twitching
pains in the stomach
side
abdomen
radiating
back
rapid weight gain
reddening of the skin
ears
seizures
shakiness
slurred speech
swelling of the eyes
nose
swelling of the face
ankles
hands
trouble breathing
unusual tiredness
weakness
vomiting
yellow eyes
skin
diarrhea
acid
sour stomach
belching
decreased appetite
general feeling of discomfort
illness
heartburn or indigestion
lack
loss of strength
stomach discomfort
pain
bleeding
blistering
burning
coldness
discoloration of the skin
feeling of pressure
hives
infection
inflammation
itching
lumps
numbness
pain
rash
redness
scarring
soreness
swelling
tenderness
tingling
ulceration
warmth at the injection site